DRI Healthcare Trust Total Assets
DRI Healthcare Trust total assets. Based on the latest financial reports, DRI Healthcare Trust (DHT-U) holds total assets worth $967.26 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of DRI Healthcare Trust for the company's overall valuation and market capitalisation.
Total Assets of DRI Healthcare Trust (2020–2024)
Total assets of DRI Healthcare Trust from 2020 to 2024. This chart illustrates how DRI Healthcare Trust's total assets have evolved over time, based on quarterly financial data. See DHT-U stock price for real-time trading data and today's change.
DRI Healthcare Trust - Asset Composition Analysis
DRI Healthcare Trust Total Assets Breakdown (December 2024)
DRI Healthcare Trust total assets breakdown as of December 2024. DRI Healthcare Trust's total assets of $967.26 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $823.94 Million | 83.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of DRI Healthcare Trust to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DRI Healthcare Trust's current assets represent 0.0% of total assets in 2024, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, down from 100.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 83.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 83.7% of total assets.
DRI Healthcare Trust Competitors by Total Assets
Key competitors of DRI Healthcare Trust based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
DRI Healthcare Trust - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 5.80 | 33.38 |
| Quick Ratio | 1.36 | 5.84 | 33.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $26.08 Million | $124.48 Million | $140.91 Million |
DRI Healthcare Trust - Advanced Valuation Insights
This section examines the relationship between DRI Healthcare Trust's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.60 |
| Asset Growth Rate (YoY) | 18.0% |
| Total Assets | $984.87 Million |
| Market Capitalization | $593.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values DRI Healthcare Trust's assets below their book value (0.60x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DRI Healthcare Trust's assets grew by 18.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DRI Healthcare Trust (2020–2024)
The table below shows the annual total assets of DRI Healthcare Trust from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $984.87 Million | +17.95% |
| 2023-12-31 | $834.96 Million | +31.82% |
| 2022-12-31 | $633.42 Million | +45.05% |
| 2021-12-31 | $436.69 Million | +4366949900.00% |
| 2020-12-31 | $10.00 | -- |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.